Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
MC
Marc Creus
CEO
abbmira therapeutics AG
Publications
20
Funding
0
Patents
0
Designed evolution of artificial metalloenzymes: protein catalysts made to order
Organic & biomolecular chemistry 5 (12), 1835-1844, 2007
Label-free detection of single protein molecules and protein− protein interactions using synthetic nanopores
Analytical chemistry 80 (12), 4651-4658, 2008
Artificial metalloenzyme for enantioselective sulfoxidation based on vanadyl-loaded streptavidin
Journal of the American Chemical Society 130 (25), 8085-8088, 2008
X-ray structure and designed evolution of an artificial transfer hydrogenase
Angewandte Chemie 120 (8), 1422, 2008
Artificial metalloenzymes for asymmetric allylic alkylation on the basis of the biotin-avidin technology
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH- 47 (4), 701, 2008
Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation
Journal of hepatology 53 (6), 1101-1107, 2010
OsO4⋅ Streptavidin: A Tunable Hybrid Catalyst for the Enantioselective cis‐Dihydroxylation of Olefins
Angewandte Chemie-International Edition 50 (46), 10863, 2011
MED20 mutation associated with infantile basal ganglia degeneration and brain atrophy
European journal of pediatrics 174, 113-118, 2015
Chemo‐Genetic Optimization of DNA Recognition by Metallodrugs using a Presenter‐Protein Strategy
Chemistry–A European Journal 16 (43), 12883-12889, 2010
CFTR gene mutations in pancreatitis: Frequency and clinical manifestations in an Austrian patient cohort.
Wiener klinische Wochenschrift 119 (17-18), 527-533, 2007
A biomimetic cerium-based biosensor for the direct visual detection of phosphate under physiological conditions
Chemical Communications 55 (99), 14894-14897, 2019
Plasmid-mediated colistin resistance in a patient infected with Klebsiella pneumoniae
The Lancet Infectious Diseases 16 (9), 998-999, 2016
Second Generation Artificial Hydrogenases Based on the Biotin‐Avidin Technology: Improving Activity, Stability and Selectivity by Introduction of Enantiopure Amino Acid Spacers
Advanced Synthesis & Catalysis 349 (11‐12), 1923-1930, 2007
The SIB Swiss Institute of Bioinformatics' resources: focus on curated databases.
Nucleic Acids Research 44 (D1), 27-37, 2016
Activation and inactivation of the iron hormone hepcidin: Biochemical characterization of prohepcidin cleavage and sequential degradation to N-terminally truncated hepcidin …
Blood Cells, Molecules, and Diseases 43 (2), 169-179, 2009
Improving the enantioselectivity of artificial transfer hydrogenases based on the biotin–streptavidin technology by combinations of point mutations
Inorganica Chimica Acta 363 (3), 601-604, 2010
Zinc-selective inhibition of the promiscuous bacterial amide-hydrolase DapE: implications of metal heterogeneity for evolution and antibiotic drug design
Metallomics 6 (1), 88-95, 2014
Burkavidin: A novel secreted biotin-binding protein from the human pathogen Burkholderia pseudomallei
Protein expression and purification 77 (2), 131-139, 2011
Reversible biofunctionalization of surfaces with a switchable mutant of avidin
Bioconjugate chemistry 24 (10), 1656-1668, 2013
Selectivity of Inhibition of N‐Succinyl‐l,l‐Diaminopimelic Acid Desuccinylase in Bacteria: The product of dapE‐gene Is Not the Target of l‐Captopril Antimicrobial …
Bioinorganic chemistry and applications 2011 (1), 306465, 2011
MC
Marc Creus
CEO
abbmira therapeutics AG
Work experience
abbmira therapeutics AG
CEO
University of Basel
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
Biochemistry
Biopharmaceutics
Biotechnology
Chemistry
Immunology
Immunotherapy
Last updated Mar 2025
Report Error
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Subscribe
Company
About
Blog
Careers
Halo Awards
Support
FAQs
Help center
Feature requests
Contact support
Sponsors
Customer stories
Privacy Policy
Terms of Service
© 2026 Halo Cures, Inc.